STANCANELLI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 885
NA - Nord America 740
AS - Asia 331
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
OC - Oceania 1
Totale 1.964
Nazione #
US - Stati Uniti d'America 736
IE - Irlanda 223
IT - Italia 182
CN - Cina 167
SE - Svezia 143
PL - Polonia 123
SG - Singapore 110
DE - Germania 76
FI - Finlandia 50
FR - Francia 44
IN - India 43
BE - Belgio 14
GB - Regno Unito 14
EU - Europa 5
NL - Olanda 5
VN - Vietnam 5
ID - Indonesia 4
RU - Federazione Russa 4
CA - Canada 3
CL - Cile 2
ES - Italia 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
HK - Hong Kong 1
MX - Messico 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
Totale 1.964
Città #
Dublin 222
Chandler 178
Warsaw 122
Nyköping 102
Singapore 80
Beijing 72
Messina 54
Ann Arbor 49
Munich 49
Ashburn 46
Helsinki 39
Princeton 36
Medford 32
Jacksonville 30
Des Moines 22
Bremen 21
Hyderabad 20
Pune 19
Cambridge 18
Dearborn 18
Wilmington 15
Boardman 14
Duncan 12
Houston 12
Jinan 12
Brussels 10
San Mateo 10
Redwood City 9
Shenyang 9
Livorno 7
Ningbo 7
Los Angeles 6
Nanjing 6
Seattle 6
Taizhou 6
Woodbridge 6
Zhengzhou 6
Hebei 5
Nanchang 5
New York 5
North Brunswick 5
Padova 5
Changsha 4
Dong Ket 4
Falls Church 4
Fuzhou 4
Jakarta 4
Tianjin 4
Waanrode 4
Chicago 3
Collegeville 3
Como 3
Hangzhou 3
Lancaster 3
Lanzhou 3
Rome 3
Bagheria 2
Cosenza 2
Guangzhou 2
Haikou 2
Inverigo 2
Kemerovo 2
London 2
Lucca 2
Milan 2
Shanghai 2
Taiyuan 2
Torino 2
Woodbine 2
Amsterdam 1
Belgrade 1
Bend 1
Bologna 1
Bracknell 1
Bury 1
Clarks Summit 1
Clifton 1
Görwihl 1
Haimen 1
Hanoi 1
Hong Kong 1
Hunedoara 1
Huntington 1
Jeffries 1
Jiaxing 1
Kiev 1
Kraków 1
La Canada Flintridge 1
Lago 1
Lahore 1
Leduc 1
Leninsk-kuznetskiy 1
Lille 1
Melbourne 1
Modena 1
Montréal 1
New Delhi 1
Norwalk 1
Ooltewah 1
Peckville 1
Totale 1.513
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 156
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 144
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 128
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 119
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 116
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 105
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 72
A Nouvel serum MicroRNA signature to screen ATTR 72
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 69
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 69
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 69
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 61
Autonomic nervous system involvement in spinal muscular atrophy. 58
Considerable post-partum worsening in a patient with CMT2E 54
null 54
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 53
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 52
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 51
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 50
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 48
Psychosocial impact of sport activity in neuromuscular disorders 47
Autonomic involvement in subacute and chronic immune-mediated neuropathies 44
The THAOS: record of patients from our site. 44
Prominent distal lower limbs involvement with hyperreflexia in a family with seipin related axonal motorneuropathy. 42
Usefulness of combining electrocardiogram and echocardiography findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation 38
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 37
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 36
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 35
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 34
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 32
TTR-FAP: a single-center experience in Sicily, an Italian endemic area 30
Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A. 20
Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series 17
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure 14
Autonomic Involvement in Subacute and Chronic Immune-Mediated Neuropathies 5
Totale 2.075
Categoria #
all - tutte 8.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020307 0 0 0 0 0 0 29 51 29 110 38 50
2020/2021274 7 24 52 17 62 24 20 10 13 28 8 9
2021/2022247 12 38 0 19 13 4 26 13 12 5 17 88
2022/2023640 56 64 32 51 64 43 6 28 268 4 16 8
2023/2024174 13 23 10 13 13 49 7 6 1 22 2 15
2024/2025257 24 8 20 49 41 53 62 0 0 0 0 0
Totale 2.075